Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#NBY 🔥 big gap upside! can it break $1 and move 50% another up? $NBY
Back to .77
NBY 1.02 + 102% still going energizer bunny
BLUE BELL, Pa., Sept. 20, 2024 /PRNewswire/ -- Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye health and companion animals, announced today that its subsidiary, PRN Physician Recommended Nutriceuticals, LLC, has entered into a definitive asset purchase agreement to acquire the assets of the Avenova® brand (the "Brand") and business from NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay"). The Brand offers several products for ocular health including cleansing sprays, absorbent wipes, and heated eye masks. The Brand's leading product, the Avenova® Lid & Lash Cleansing Spray, is a hypochlorous acid spray utilized to promote eye hygiene. Avenova® products are sold through the direct-to-consumer, professional, and retail pharmacy channels. The transaction is anticipated to close in the fourth quarter of 2024, subject to the satisfaction of customary closing conditions.
Acumen Health Holdings
The acquisition of the Brand will bolster PRN's existing portfolio and strengthen PRN's commitment to deliver high-quality products that have a meaningful impact on patients' eye health. PRN will leverage their existing sales force and relationships with optometrists and ophthalmologists to expand access and awareness of Avenova® products.
"The Brand pioneered the use of hypochlorous acid in eyecare and has a long history of success in the professional channel," said Scott Woodruff, CEO of Acumen Health Holdings. "This exciting acquisition broadens PRN's existing eye health product portfolio and allows PRN to better serve patients through offering an expanded suite of science-based eye health products."
The deal builds on PRN's strategy to grow its presence in the eye health market organically and through acquisitions. Avenova® will represent the sixth add-on acquisition completed by PRN in the past 5 years.
Please see the NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) press release for information regarding their go-forward plans following this transaction.
Alex Putala
(920) 255-4972
960 Harvest Drive, Suite B250
Blue Bell, PA 19422
Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/acumen-health-holdings-acumen-to-acquire-the-avenova-brand-from-novabay-pharmaceuticals-302253803.html
SOURCE Acumen Health Holdings
A couple Pennie’s a day keeps the bill collectors away……lol.
$$ NBY $$
Looks like good old NovaBay is reawakening……how nice !
$$ NBY $$
Why? Because you think it stopped dropping?
Looks like the time to buy is upon us ?
You were right about the no brain part. Shareholders destroyed.
No brainer continued gainer, in my modest opinion !!
$$ NBY $$
I was gonna buy today this is why I dont like to hold this thing overnight LOL
Thank you for mentioning RS. I was about to load up. Maybe I will after the 30th.
See you in post market for the spike!
$NBY all we need is a little bit of news and this should skyrocket! Let’s go!
$NBY they’re holding it down, let her rip!!!
NBY..........................................https://stockcharts.com/h-sc/ui?s=NBY&p=W&b=5&g=0&id=p86431144783
Fish on $$$$$$ start reeling $$$$$$$$$
News out... trading up...good potential here today
Watch and see what happens when this blasts through.157
Sound all alarms!!!! tsunami warning!!!!
Here’s the dip!!! To the mooooooooon!!!!
Bust the shorts ass with no vaseline dudes!!!
Need to bust down the 15’s walls, blue skies up ahead
Correct dude!! Pop your pills and get ready to fly!!!
Is 6.5 million share count outstanding correct??
Put the shorts under the press and squeeze the shit out of them
Followers
|
88
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
1685
|
Created
|
04/07/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |